Staccato Alprazolam as rescue medication for adolescents with epilepsy
Research Question:
What is the safety profile of a single dose of Staccato Alprazolam in adolescents
with epilepsy?
Basic Study Information
Purpose:
After a screening visit, subjects between the age of 12-17 would be admitted to the
Clinical Research Center for 36 hours. During their admission, they would receive
a single dose of alprazolam by inhaling the medication into their lungs. They would
be observed for 36 hours with 6 sets of vital signs and blood draws. Eligibility:
Adolescents with epilepsy (either focal and/or generalized), ages 12-17, who weigh
below 110 lbs and who are in generally good health. Potential subjects must currently
be taking at least one medication for their epilepsy.
Location: University of Rochester Medical Center - Strong Memorial Hospital
Study Reference #: 6200
Lead Researcher (Principal Investigator)
Lead Researcher:
Thomas Wychowski
Study Contact Information
Study Coordinator: Cate Concannon
Phone: (585) 275-0404
Email: cathleen_concannon@urmc.rochester.edu
Additional Study Details
Number of Visits:
2 to 5
Parking:
Reimbursed
Transportation Coverage:
Yes
Reimbursement:
Yes
Learn More About These Conditions
More information about Epilepsy
Trial Not Found
The study you are looking for is not active at this time.
Return to Search